Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Pulmonary Medicine
Published in: BMC Pulmonary Medicine 1/2014

Open Access 01-12-2014 | Research article

Genetic polymorphisms and risk of recurrent wheezing in pediatric age

Authors: Susanna Esposito, Valentina Ierardi, Cristina Daleno, Alessia Scala, Leonardo Terranova, Claudia Tagliabue, Walter Peves Rios, Claudio Pelucchi, Nicola Principi

Published in: BMC Pulmonary Medicine | Issue 1/2014

Login to get access

Abstract

Background

Wheezing during early life is a very common disorder, but the reasons underlying the different wheezing phenotypes are still unclear. The aims of this study were to analyse the potential correlations between the risk of developing recurrent wheezing and the presence of specific polymorphisms of some genes regulating immune system function, and to study the relative importance of the associations of different viruses and genetic polymorphisms in causing recurrent episodes.

Methods

The study involved 119 otherwise healthy infants admitted to hospital for a first episode of wheezing (74 of whom subsequently experienced recurrent episodes) and 119 age- and sex-matched subjects without any history of respiratory problem randomly selected from those attending our outpatient clinic during the study period. All of the study subjects were followed up for two years, and 47 single nucleotide polymorphisms (SNPs) in 33 candidate genes were genotyped on whole blood using an ABI PRISM 7900 HT Fast Real-time instrument.

Results

IL8-rs4073AT, VEGFA-rs833058CT, MBL2-rs1800450CT and IKBKB-rs3747811AT were associated with a significantly increased risk of developing wheezing (p = 0.02, p = 0.03, p = 0.05 and p = 0.0018), whereas CTLA4-rs3087243AG and NFKBIB-rs3136641TT were associated with a significantly reduced risk (p = 0.05 and p = 0.04). IL8-rs4073AT, VEGFA-rs2146323AA and NFKBIA-rs2233419AG were associated with a significantly increased risk of developing recurrent wheezing (p = 0.04, p = 0.04 and p = 0.03), whereas TLR3-rs3775291TC was associated with a significantly reduced risk (p = 0.03). Interestingly, the study of gene-environment interactions showed that rhinovirus was significantly associated with recurrent wheezing in the presence of IL4Ra-rs1801275GG and G (odds ratio [OR] 6.03, 95% confidence interval [CI]: 1.21-30.10, p = 0.03) and MAP3K1-rs702689AA (OR 4.09, 95% CI: 1.14-14.61, p = 0.03).

Conclusions

This study shows a clear relationship between the risk of wheezing and polymorphisms of some genes involved in the immune response. Although further studies are needed to confirm the results, these findings may be useful for the early identification of children at the highest risk of developing recurrent episodes and possibly subsequent asthma.
Literature
1.
Martinez F, Wright A, Taussig L, Holberg CJ, Halonen M, Morgan WJ: Asthma and wheezing in the first six years of life. N Engl J Med. 1995, 332: 133-138. 10.1056/NEJM199501193320301.CrossRefPubMed
2.
3.
Jackson DJ: Early-life viral infections and the development of asthma: a target for asthma prevention?. Curr Opin Allergy Clin Immunol. 2014, 14: 131-136. 10.1097/ACI.0000000000000047.CrossRefPubMedPubMedCentral
4.
Hopp RJ: Recurrent wheezing in infants and young children and bronchial hyperresponsiveness: a perspective. Clin Rev Allergy Immunol. 2003, 24: 7-18. 10.1385/CRIAI:24:1:7.CrossRefPubMed
5.
Bloomberg GR: The influence of environment, as represented by diet and air pollution, upon incidence and prevalence of wheezing illnesses in young children. Curr Opin Allergy Clin Immunol. 2011, 11: 144-149. 10.1097/ACI.0b013e3283445950.CrossRefPubMed
6.
Escobar GJ, Masaquel AS, Li SX, Walsh EM, Kipnis P: Persistent recurring wheezing in the fifth year of life after laboratory-confirmed, medically attended respiratory syncytial virus infection in infancy. BMC Pediatr. 2013, 13: 97-10.1186/1471-2431-13-97.CrossRefPubMedPubMedCentral
7.
Takeyama A, Hashimoto K, Sato M, Sato T, Tomita Y, Maeda R, Ito M, Katayose M, Kawasaki Y, Hosoya M: Clinical and epidemiologic factors related to subsequent wheezing after virus-induced lower respiratory tract infections in hospitalized pediatric patients younger than 3 years. Eur J Pediatr. 2014, ᅟ: ᅟ-Epub Feb 18
8.
Halfhide C, Smith RL: Innate immune response and bronchiolitis and preschool recurrent wheezing. Pediatr Resp Rev. 2008, 9: 251-262. 10.1016/j.prrv.2008.05.005.CrossRef
9.
Janssen R, Bont L, Siezen CL, Hodemaekers HM, Ermers MJ, Doornbos G, Van’t Slot R, Wijmenga C, Goeman JJ, Kimpen JL, Van Houwelingen HC, Kimman TG, Hoebee B: Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes. J Infect Dis. 2007, 196: 826-834. 10.1086/520886.CrossRefPubMed
10.
Daley D, Park JE, He JQ, Yan J, Akhabir L, Stefanowicz D, Becker AB, Chan-Yeung M, Bossé Y, Kozyrskyj AL, James AL, Musk AW, Laprise C, Hegele RG, Paré PD, Sandford AJ: Associations and interactions of genetic polymorphisms in innate immunity genes with early viral infections and susceptibility to asthma and asthma-related phenotypes. J Allergy Clin Immunol. 2012, 130: 1284-1293. 10.1016/j.jaci.2012.07.051.CrossRefPubMed
11.
Sharma S, Poon A, Himes BE, Lasky-Su J, Sordillo JE, Belanger K, Milton DK, Bracken MB, Triche EW, Leaderer BP, Gold DR, Litonjua AA: Association of variants in innate immune genes with asthma and eczema. Pediatr Allergy Immunol. 2012, 23: 315-323. 10.1111/j.1399-3038.2011.01243.x.CrossRefPubMed
12.
Feigin RD, Cherry JD: Textbook of Pediatric Infectious Diseases. 2014, Philadelphia, PY: W.B. Saunders Company, 7
13.
Gadsby NJ, Hardie A, Claas EC, Templeton KE: Comparison of the Luminex respiratory virus panel fast assay with in-house real-time PCR for respiratory viral infection diagnosis. J Clin Microbiol. 2010, 48: 2213-2216. 10.1128/JCM.02446-09.CrossRefPubMedPubMedCentral
14.
Pabbaraju K, Wong S, Tokaryk KL, Fonseca K, Drews SJ: Comparison of the Luminex xTAG respiratory viral panel with xTAG respiratory viral panel fast for diagnosis of respiratory virus infections. J Clin Microbiol. 2011, 49: 1738-1744. 10.1128/JCM.02090-10.CrossRefPubMedPubMedCentral
15.
Lu X, Holloway B, Dare RK, Kuypers J, Yagi S, Williams JV, Hall CB, Erdman DD: Real-time reverse transcription-PCR assay for comprehensive detection of human rhinoviruses. J Clin Microbiol. 2008, 46: 533-539. 10.1128/JCM.01739-07.CrossRefPubMed
16.
Faber TE, Schuurhof A, Vonk A, Koppelman GH, Hennus MP, Kimpen JL, Janssen R, Bont LJ: IL1RL1 gene variants and nasopharyngeal IL1RL-a levels are associated with severe RSV bronchiolitis: a multicenter cohort study. PLoS ONE. 2012, 7: e34364-10.1371/journal.pone.0034364.CrossRefPubMedPubMedCentral
17.
De Dooy JJ, Mahieu LM, Van Bever HP: The role of inflammation in the development of chronic lung disease in neonates. Eur J Pediatr. 2001, 160: 457-463. 10.1007/s004310100785.CrossRefPubMed
18.
Sharma S, Murphy AJ, Soto-Quiros ME, Avila L, Klanderman BJ, Sylvia JS, Celedón JC, Raby BA, Weiss ST: Association of VEGF polymorphisms with childhood asthma, lung function and airway responsiveness. Eur Respir J. 2009, 33: 1287-1294. 10.1183/09031936.00113008.CrossRefPubMedPubMedCentral
19.
Tulic MK, Hurrelbrink RJ, Prêle CM, Laing IA, Upham JW, Le Souef P, Sly PD, Holt PG: TLR4 polymorphisms mediate impaired responses to respiratory syncytial virus and lipopolysaccharide. J Immunol. 2007, 179: 132-140. 10.4049/jimmunol.179.1.132.CrossRefPubMed
20.
Himes BE, Jiang X, Hu R, Wu AC, Lasky-Su JA, Klanderman BJ, Senter-Sylvia J, Lima JJ, Irvin CG, Peters SP, Meyers DA, Bleecker ER, Kubo M, Tamari M, Nakamura Y, Szefler SJ, Lemanske RF, Zeiger RS, Strunk RC, Martinez FD, Hanrahan JP, Koppelman GH, Postma DS, Nieuwenhuis MA, Vonk JM, Panettieri RA, Markezich A, Israel E, Carey VJ, Tantisira KG, et al: Genome-wide association analysis in asthma subjects identifies SPATS2L as a novel bronchodilator response gene. PLoS Genet. 2012, 8: e1002824-10.1371/journal.pgen.1002824.CrossRefPubMedPubMedCentral
21.
Nuolivirta K, He Q, Gröndahl-Yli-Hannuksela K, Koponen P, Korppi M, Helminen M: Mannose-binding lectin gene polymorphisms in infants with bronchiolitis and post-bronchiolitis wheezing. Allergol Int. 2012, 61: 305-309.CrossRefPubMed
22.
Goetghebuer T, Isles K, Moore C, Thomson A, Kwiatkowski D, Hull J: Genetic predisposition to wheeze following respiratory syncytial virus bronchiolitis. Clin Exp Allergy. 2004, 34: 801-803. 10.1111/j.1365-2222.2004.1947.x.CrossRefPubMed
23.
Tadaki H, Arakawa H, Sugiyama M, Ozawa K, Mizuno T, Mochizuki H, Tokuyama K, Morikawa A: Association of cord blood cytokine levels with wheezy infants in the first year of life. Pediatr Allergy Immunol. 2009, 20: 227-233. 10.1111/j.1399-3038.2008.00783.x.CrossRefPubMed
24.
Hoshino M, Takahashi M, Aoike N: Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol. 2001, 107: 295-301. 10.1067/mai.2001.111928.CrossRefPubMed
25.
McColley SA, Stellmach V, Boas SR, Jain M, Crawford SE: Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation. Am J Respir Crit Care Med. 2000, 161: 1877-1880. 10.1164/ajrccm.161.6.9905022.CrossRefPubMed
26.
Kanazawa H, Asai K, Nomura S: Vascular endothelial growth factor as a non-invasive marker of pulmonary vascular remodeling in patients with bronchitis-type of COPD. Respir Res. 2007, 8: 22-10.1186/1465-9921-8-22.CrossRefPubMedPubMedCentral
27.
Nishigaki Y, Fujiuchi S, Yamazaki Y, Matsumoto H, Takeda A, Fujita Y, Okamoto K, Fujikane T, Shimizu T, Kikuchi K: Increased vascular endothelial growth factor in acute eosinophilic pneumonia. Eur Respir J. 2003, 21: 774-778. 10.1183/09031936.03.00085903.CrossRefPubMed
28.
Choi IS, Byeon JH, Yoo Y, Lee KC, Choung JT: Increased serum interleukin-5 and vascular endothelial growth factor in children with acute mycoplasma pneumonia and wheeze. Pediatr Pulmonol. 2009, 44: 423-428. 10.1002/ppul.20961.CrossRefPubMed
29.
Leung TF, Tang NL, Sung YM, Li CY, Ma SL, Lam CW, Wong GW: Genetic association study between mbl2 and asthma phenotypes in Chinese children. Pediatr Allergy Immunol. 2006, 17: 501-507. 10.1111/j.1399-3038.2006.00446.x.CrossRefPubMed
30.
Pannicke U, Baumann B, Fuchs S, Henneke P, Rensing-Ehl A, Rizzi M, Janda A, Hese K, Schlesier M, Holzmann K, Borte S, Laux C, Rump EM, Rosenberg A, Zelinski T, Schrezenmeier H, Wirth T, Ehl S, Schroeder ML, Schwarz K: Deficiency of innate and acquired immunity caused by an IKBKB mutation. N Engl J Med. 2013, 369: 2504-2514. 10.1056/NEJMoa1309199.CrossRefPubMed
31.
Bulek K, Liu C, Swaidani S, Wang L, Page RC, Gulen MF, Herjan T, Abbadi A, Qian W, Sun D, Lauer M, Hascall V, Misra S, Chance MR, Aronica M, Hamilton T, Li X: The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation. Nat Immunol. 2011, 12: 844-852. 10.1038/ni.2080.CrossRefPubMedPubMedCentral
32.
Bazzi MD, Sultan MA, Al Tassan N, Alanazi M, Al-Amri A, Al-Hajjaj MS, Al-Muhsen S, Alba-Concepcion K, Warsy A: Interleukin 17A and F and asthma in Saudi Arabia: gene polymorphisms and protein levels. J Investig Allergol Clin Immunol. 2011, 21: 551-555.PubMed
33.
Sheikh A, Smeeth L, Hubbard R: There is no evidence of an inverse relationship between TH2-mediated atopy and TH1-mediated autoimmune disorders: lack of support for the hygiene hypothesis. J Allergy Clin Immunol. 2003, 111: 131-135. 10.1067/mai.2003.8.CrossRefPubMed
34.
Borrego LM, Arroz MJ, Videira P, Martins C, Guimarães H, Nunes G, Papoila AL, Trindade H: Regulatory cells, cytokine pattern and clinical risk factors for asthma in infants and young children with recurrent wheeze. Clin Exp Allergy. 2009, 39: 1160-1169. 10.1111/j.1365-2222.2009.03253.x.CrossRefPubMed
35.
Ermers MJ, Janssen R, Onland-Moret NC, Hodemaekers HM, Rovers MM, Houben ML, Kimpen JL, Bont LJ: IL10 family member genes IL19 and IL20 are associated with recurrent wheeze after respiratory syncytial virus bronchiolitis. Pediatr Res. 2011, 70: 518-523.CrossRefPubMed
36.
Torres D, Dieudonné A, Ryffel B, Lassalle P, Trottein F, Gosset P: Double-stranded RNA exacerbates pulmonary allergic reaction through TLR3: implication of airway epithelium and dendritic cells. J Immunol. 2010, 185: 451-459. 10.4049/jimmunol.0902833.CrossRefPubMed
37.
Wang Q, Miller DJ, Bowman ER, Nagarkar DR, Schneider D, Zhao Y, Linn MJ, Goldsmith AM, Bentley JK, Sajjan US, Hershenson MB: MDA5 and TLR3 initiate pro-inflammatory signaling pathways leading to rhinovirus-induced airways inflammation and hyperresponsiveness. PLoS Pathog. 2011, 7: e1002070-10.1371/journal.ppat.1002070.CrossRefPubMedPubMedCentral
38.
Nuolivirta K, He Q, Vuononvirta J, Koponen P, Helminen M, Korppi M: Toll-like receptor 3 L412F polymorphisms in infants with bronchiolitis and postbronchiolitis wheezing. Pediatr Infect Dis J. 2012, 31: 920-923. 10.1097/INF.0b013e31825aff25.CrossRefPubMed
39.
Ermers MJ, Hoebee B, Hodemaekers HM, Kimman TG, Kimpen JL, Bont L: IL-13 genetic polymorphism identifies children with late wheezing after respiratory syncytial virus infection. J Allergy Clin Immunol. 2007, 119: 1086-1091. 10.1016/j.jaci.2006.12.655.CrossRefPubMed
40.
Beghé B, Barton S, Rorke S, Peng Q, Sayers I, Gaunt T, Keith TP, Clough JB, Holgate ST, Holloway JW: Polymorphisms in the interleukin-4 and interleukin-4 receptor alpha chain genes confer susceptibility to asthma and atopy in a Caucasian population. Clin Exp Allergy. 2003, 33: 1111-1117. 10.1046/j.1365-2222.2003.01731.x.CrossRefPubMed
41.
Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L, Symington P, O’Toole S, Myint SH, Tyrrell DA: Community study of role of viral infections in exacerbations of asthma in 9–11 year old children. BMJ. 1995, 310: 1225-1229. 10.1136/bmj.310.6989.1225.CrossRefPubMedPubMedCentral
42.
43.
Turchiarelli V, Schinkel J, Molenkamp R, Foschino Barbaro MP, Carpagnano GE, Spanevello A, Lutter R, Bel EH, Sterk PJ: Repeated virus identification in the airways of patients with mild and severe asthma during prospective follow-up. Allergy. 2011, 66: 1099-1106. 10.1111/j.1398-9995.2011.02600.x.CrossRefPubMed
44.
Wark PA, Johnston SL, Bucchieri F, Powell R, Puddicombe S, Laza-Stanca V, Holgate ST, Davies DE: Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med. 2005, 201: 937-947. 10.1084/jem.20041901.CrossRefPubMedPubMedCentral
45.
Contoli M, Message SD, Laza-Stanca V, Edwards MR, Wark PA, Bartlett NW, Kebadze T, Mallia P, Stanciu LA, Parker HL, Slater L, Lewis-Antes A, Kon OM, Holgate ST, Davies DE, Kotenko SV, Papi A, Johnston SL: Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med. 2006, 12: 1023-1026. 10.1038/nm1462.CrossRefPubMed
46.
Subrata LS, Bizzintino J, Mamessier E, Bosco A, McKenna KL, Wikström ME, Goldblatt J, Sly PD, Hales BJ, Thomas WR, Laing IA, LeSouëf PN, Holt PG: Interactions between innate antiviral and atopic immunoinflammatory pathways precipitate and sustain asthma exacerbations in children. J Immunol. 2009, 183: 2793-2800. 10.4049/jimmunol.0900695.CrossRefPubMed
47.
Szczepankiewicz A, Sobkowiak P, Rachel M, Bręborowicz A, Schoneich N, Bruce K, Kycler Z, Wojsyk-Banaszak I, Dmitrzak-Węglarz M: Multilocus analysis of candidate genes involved in neurogenic inflammation in pediatric asthma and related phenotypes: a case–control study. J Asthma. 2012, 49: 329-335. 10.3109/02770903.2012.669442.CrossRefPubMed
Metadata
Title
Genetic polymorphisms and risk of recurrent wheezing in pediatric age
Authors
Susanna Esposito
Valentina Ierardi
Cristina Daleno
Alessia Scala
Leonardo Terranova
Claudia Tagliabue
Walter Peves Rios
Claudio Pelucchi
Nicola Principi
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2014
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/1471-2466-14-162

Other articles of this Issue 1/2014

BMC Pulmonary Medicine 1/2014 Go to the issue

Research article

Extrafine Beclomethasone/formoterol compared to Fluticasone/salmeterol Combination Therapy in COPD

Study protocol

Genetic test to stop smoking (GeTSS) trial protocol: randomised controlled trial of a genetic test (Respiragene) and Auckland formula to assess lung cancer risk

Research article

Randomized study of the safety, pharmacokinetics, and bronchodilatory efficacy of a proprietary glycopyrronium metered-dose inhaler in study patients with chronic obstructive pulmonary disease

Research article

Correlates of exposure to secondhand smoke (SHS) at home among non-smoking adults in Bangladesh: findings from the ITC Bangladesh survey

Research article

Determinants of arterial stiffness in COPD

Research article

Intestinal current measurement versus nasal potential difference measurements for diagnosis of cystic fibrosis: a case–control study
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits